These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 9038563

  • 21. [Role of suindac in the treatment of familial adenomatous polyposis coli].
    Landauer S, Halimi C, Caulin C, Bergmann JF.
    Therapie; 1999; 54(6):675-82. PubMed ID: 10709439
    [Abstract] [Full Text] [Related]

  • 22. Combination of Sulindac and Bexarotene for Prevention of Intestinal Carcinogenesis in Familial Adenomatous Polyposis.
    Bowen CM, Walter L, Borras E, Wu W, Ozcan Z, Chang K, Bommi PV, Taggart MW, Thirumurthi S, Lynch PM, Reyes-Uribe L, Scheet PA, Sinha KM, Vilar E.
    Cancer Prev Res (Phila); 2021 Sep; 14(9):851-862. PubMed ID: 34266857
    [Abstract] [Full Text] [Related]

  • 23. High prevalence of adenomatous polyps of the duodenal papilla in familial adenomatous polyposis.
    Alexander JR, Andrews JM, Buchi KN, Lee RG, Becker JM, Burt RW.
    Dig Dis Sci; 1989 Feb; 34(2):167-70. PubMed ID: 2536604
    [Abstract] [Full Text] [Related]

  • 24. The effects of sulindac on colorectal proliferation and apoptosis in familial adenomatous polyposis.
    Pasricha PJ, Bedi A, O'Connor K, Rashid A, Akhtar AJ, Zahurak ML, Piantadosi S, Hamilton SR, Giardiello FM.
    Gastroenterology; 1995 Sep; 109(3):994-8. PubMed ID: 7657130
    [Abstract] [Full Text] [Related]

  • 25. Sulindac in familial adenomatous polyposis: evaluation by nuclear morphometry.
    Fernández-López F, Conde-Freire R, Cadarso-Suárez C, García-Iglesias J, Puente-Domínguez JL, Potel-Lesquereux J.
    Eur J Surg; 2001 May; 167(5):375-81. PubMed ID: 11419555
    [Abstract] [Full Text] [Related]

  • 26. Upper gastrointestinal neoplasia in familial polyposis.
    Kurtz RC, Sternberg SS, Miller HH, Decosse JJ.
    Dig Dis Sci; 1987 May; 32(5):459-65. PubMed ID: 3032535
    [Abstract] [Full Text] [Related]

  • 27. Sulindac sulfone induced regression of rectal polyps in patients with familial adenomatous polyposis.
    Stoner GD, Budd GT, Ganapathi R, DeYoung B, Kresty LA, Nitert M, Fryer B, Church JM, Provencher K, Pamukcu R, Piazza G, Hawk E, Kelloff G, Elson P, van Stolk RU.
    Adv Exp Med Biol; 1999 May; 470():45-53. PubMed ID: 10709673
    [Abstract] [Full Text] [Related]

  • 28. Ursodeoxycholic acid counteracts celecoxib in reduction of duodenal polyps in patients with familial adenomatous polyposis: a multicentre, randomized controlled trial.
    van Heumen BW, Roelofs HM, Vink-Börger ME, Dekker E, Mathus-Vliegen EM, Dees J, Koornstra JJ, Langers AM, Nagtegaal ID, Kampman E, Peters WH, Nagengast FM.
    Orphanet J Rare Dis; 2013 Aug 06; 8():118. PubMed ID: 23919274
    [Abstract] [Full Text] [Related]

  • 29. Effect of sulindac treatment for attenuated familial adenomatous polyposis with a new germline APC mutation at codon 161: report of a case.
    Esaki M, Matsumoto T, Mizuno M, Kobori Y, Yoshimura R, Yao T, Iida M.
    Dis Colon Rectum; 2002 Oct 06; 45(10):1397-402; discussion 1402-6. PubMed ID: 12394442
    [Abstract] [Full Text] [Related]

  • 30. Gastric and duodenal polyps in familial adenomatous polyposis: a prospective study of the nature and prevalence of upper gastrointestinal polyps.
    Sarre RG, Frost AG, Jagelman DG, Petras RE, Sivak MV, McGannon E.
    Gut; 1987 Mar 06; 28(3):306-14. PubMed ID: 3032754
    [Abstract] [Full Text] [Related]

  • 31. Upper gastrointestinal pathology in familial adenomatous polyposis: results from a prospective study of 102 patients.
    Domizio P, Talbot IC, Spigelman AD, Williams CB, Phillips RK.
    J Clin Pathol; 1990 Sep 06; 43(9):738-43. PubMed ID: 2170464
    [Abstract] [Full Text] [Related]

  • 32. Duodenal polyposis and malignancy in a case of familial polyposis coli.
    Buchi KN, Becker JM, Burt RW.
    Am J Gastroenterol; 1988 Sep 06; 83(9):985-7. PubMed ID: 2843037
    [Abstract] [Full Text] [Related]

  • 33. Gastroduodenal and ileal polyps in patients treated surgically for familial polyposis coli with proctocolectomy and continent ileostomy.
    Ojerskog B, Myrvold HE, Nilsson LO, Philipson BM, Ahrén C.
    Acta Chir Scand; 1987 Sep 06; 153(11-12):681-5. PubMed ID: 2829483
    [Abstract] [Full Text] [Related]

  • 34. Rectal epithelial apoptosis in familial adenomatous polyposis patients treated with sulindac.
    Keller JJ, Offerhaus GJ, Polak M, Goodman SN, Zahurak ML, Hylind LM, Hamilton SR, Giardiello FM.
    Gut; 1999 Dec 06; 45(6):822-8. PubMed ID: 10562579
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Association of Sulindac and Erlotinib vs Placebo With Colorectal Neoplasia in Familial Adenomatous Polyposis: Secondary Analysis of a Randomized Clinical Trial.
    Samadder NJ, Kuwada SK, Boucher KM, Byrne K, Kanth P, Samowitz W, Jones D, Tavtigian SV, Westover M, Berry T, Jasperson K, Pappas L, Smith L, Sample D, Burt RW, Neklason DW.
    JAMA Oncol; 2018 May 01; 4(5):671-677. PubMed ID: 29423501
    [Abstract] [Full Text] [Related]

  • 37. Disappearance of duodenal polyps in Gardner's syndrome with sulindac therapy.
    Parker AL, Kadakia SC, Maccini DM, Cassaday MA, Angueira CE.
    Am J Gastroenterol; 1993 Jan 01; 88(1):93-4. PubMed ID: 8420281
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Adenocarcinoma in the rectal segment in familial polyposis coli is not prevented by sulindac therapy.
    Niv Y, Fraser GM.
    Gastroenterology; 1994 Sep 01; 107(3):854-7. PubMed ID: 8076772
    [Abstract] [Full Text] [Related]

  • 40. [The effects of sulindac on the pathology of colorectal remnant polyps of familial adenomatous polyposis (FAP) patients].
    Li J, Lv YM, Jin Z, Cui RL.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Aug 18; 37(4):371-3. PubMed ID: 16086054
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.